Catheter Precision (VTAK) Shares Outstanding (Diluted Average) (2021 - 2022)
Catheter Precision (VTAK) reported Shares Outstanding (Diluted Average) of $1.0 million for Q4 2022, up 923.76% year-over-year from $101000.0 in Q4 2021, and up 94588.64% quarter-over-quarter from $1092.0 in Q3 2022.
Catheter Precision (VTAK) Shares Outstanding (Diluted Average) (2021 - 2022) Analysis & Trends
Catheter Precision (VTAK) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $1.0 million in Q4 2022.
- Shares Outstanding (Diluted Average) for Q4 2022 came in at $1.0 million, up 923.76% year-over-year; the trailing twelve-month figure through Dec 2022 was $1.0 million (up 923.76% YoY), and the FY2022 annual result was $1.0 million, up 923.76% from the prior year.
- Shares Outstanding (Diluted Average) improved to $1.0 million in Q4 2022 per VTAK's latest filing, from $1092.0 in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $1.0 million in Q4 2022 and troughed at $128.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Catheter Precision | 921,210.28 | 109,210.28 | 390,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 1,092.00 |
| Dec 31, 2021 | 101,000.00 |
| Sep 30, 2021 | 128.00 |